[A new particularly active hypoglycemic sulfonamide, HB 419 (glibenclamide)].
D000818:Animals; D001786:Blood Glucose; D004285:Dogs; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects*; D051379:Mice; D010180:Pancreatectomy
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin
Etude d'un nouveau sulfamide hypoglycémiant doué d'une grande activité le HB 419 (libenclamide)